Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkers.

Whelan SA, Lu M, He J, Yan W, Saxton RE, Faull KF, Whitelegge JP, Chang HR.

J Proteome Res. 2009 Aug;8(8):4151-60. doi: 10.1021/pr900322g.

2.

Cell surface and secreted protein profiles of human thyroid cancer cell lines reveal distinct glycoprotein patterns.

Arcinas A, Yen TY, Kebebew E, Macher BA.

J Proteome Res. 2009 Aug;8(8):3958-68. doi: 10.1021/pr900278c.

3.

Lung cancer serum biomarker discovery using glycoprotein capture and liquid chromatography mass spectrometry.

Zeng X, Hood BL, Sun M, Conrads TP, Day RS, Weissfeld JL, Siegfried JM, Bigbee WL.

J Proteome Res. 2010 Dec 3;9(12):6440-9. doi: 10.1021/pr100696n. Epub 2010 Oct 28.

4.

Mass spectrometry (LC-MS/MS) identified proteomic biosignatures of breast cancer in proximal fluid.

Whelan SA, He J, Lu M, Souda P, Saxton RE, Faull KF, Whitelegge JP, Chang HR.

J Proteome Res. 2012 Oct 5;11(10):5034-45. doi: 10.1021/pr300606e. Epub 2012 Sep 20.

5.

Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.

Liu T, Qian WJ, Gritsenko MA, Camp DG 2nd, Monroe ME, Moore RJ, Smith RD.

J Proteome Res. 2005 Nov-Dec;4(6):2070-80.

6.

Enrichment and identification of glycoproteins in human saliva using lectin magnetic bead arrays.

Caragata M, Shah AK, Schulz BL, Hill MM, Punyadeera C.

Anal Biochem. 2016 Mar 15;497:76-82. doi: 10.1016/j.ab.2015.11.024. Epub 2015 Dec 30.

PMID:
26743719
7.

Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer.

Mbeunkui F, Metge BJ, Shevde LA, Pannell LK.

J Proteome Res. 2007 Aug;6(8):2993-3002. Epub 2007 Jul 4.

8.

Comparison of liquid chromatography-tandem mass spectrometry-based targeted proteomics and conventional analytical methods for the determination of P-glycoprotein in human breast cancer cells.

Yang T, Xu F, Xu J, Fang D, Yu Y, Chen Y.

J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Oct 1;936:18-24. doi: 10.1016/j.jchromb.2013.07.023. Epub 2013 Aug 3.

PMID:
23968647
9.

Assessment of lectin and HILIC based enrichment protocols for characterization of serum glycoproteins by mass spectrometry.

Calvano CD, Zambonin CG, Jensen ON.

J Proteomics. 2008 Aug 21;71(3):304-17. doi: 10.1016/j.jprot.2008.06.013. Epub 2008 Jul 4.

PMID:
18638581
10.

Combining results from lectin affinity chromatography and glycocapture approaches substantially improves the coverage of the glycoproteome.

McDonald CA, Yang JY, Marathe V, Yen TY, Macher BA.

Mol Cell Proteomics. 2009 Feb;8(2):287-301. doi: 10.1074/mcp.M800272-MCP200. Epub 2008 Oct 15.

11.

Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets.

Kulasingam V, Diamandis EP.

Mol Cell Proteomics. 2007 Nov;6(11):1997-2011. Epub 2007 Jul 25.

12.

Mapping N-linked glycosylation sites in the secretome and whole cells of Aspergillus niger using hydrazide chemistry and mass spectrometry.

Wang L, Aryal UK, Dai Z, Mason AC, Monroe ME, Tian ZX, Zhou JY, Su D, Weitz KK, Liu T, Camp DG 2nd, Smith RD, Baker SE, Qian WJ.

J Proteome Res. 2012 Jan 1;11(1):143-56. doi: 10.1021/pr200916k. Epub 2011 Dec 2.

PMID:
22136231
13.

Deglycosylation systematically improves N-glycoprotein identification in liquid chromatography-tandem mass spectrometry proteomics for analysis of cell wall stress responses in Saccharomyces cerevisiae lacking Alg3p.

Bailey UM, Schulz BL.

J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Apr 1;923-924:16-21. doi: 10.1016/j.jchromb.2013.01.026. Epub 2013 Feb 4.

PMID:
23454304
14.
15.

Shotgun glycopeptide capture approach coupled with mass spectrometry for comprehensive glycoproteomics.

Sun B, Ranish JA, Utleg AG, White JT, Yan X, Lin B, Hood L.

Mol Cell Proteomics. 2007 Jan;6(1):141-9. Epub 2006 Oct 29.

16.

Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers.

Lund R, Leth-Larsen R, Jensen ON, Ditzel HJ.

J Proteome Res. 2009 Jun;8(6):3078-90. doi: 10.1021/pr801091k.

PMID:
19341246
17.

Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.

Beretov J, Wasinger VC, Millar EK, Schwartz P, Graham PH, Li Y.

PLoS One. 2015 Nov 6;10(11):e0141876. doi: 10.1371/journal.pone.0141876. eCollection 2015.

18.

Quantification of the N-glycosylated secretome by super-SILAC during breast cancer progression and in human blood samples.

Boersema PJ, Geiger T, Wisniewski JR, Mann M.

Mol Cell Proteomics. 2013 Jan;12(1):158-71. doi: 10.1074/mcp.M112.023614. Epub 2012 Oct 22.

19.

Lectin chromatography/mass spectrometry discovery workflow identifies putative biomarkers of aggressive breast cancers.

Drake PM, Schilling B, Niles RK, Prakobphol A, Li B, Jung K, Cho W, Braten M, Inerowicz HD, Williams K, Albertolle M, Held JM, Iacovides D, Sorensen DJ, Griffith OL, Johansen E, Zawadzka AM, Cusack MP, Allen S, Gormley M, Hall SC, Witkowska HE, Gray JW, Regnier F, Gibson BW, Fisher SJ.

J Proteome Res. 2012 Apr 6;11(4):2508-20. doi: 10.1021/pr201206w. Epub 2012 Mar 13.

20.

N-glycan occupancy of Arabidopsis N-glycoproteins.

Song W, Mentink RA, Henquet MG, Cordewener JH, van Dijk AD, Bosch D, America AH, van der Krol AR.

J Proteomics. 2013 Nov 20;93:343-55. doi: 10.1016/j.jprot.2013.07.032. Epub 2013 Aug 27.

PMID:
23994444

Supplemental Content

Support Center